 | • レポートコード：MRC2203A091 • 出版社/出版日：Mordor Intelligence / 2022年1月 • レポート形態：英文、PDF、112ページ • 納品方法：Eメール（受注後2-3営業日） • 産業分類：医療 |
| Single User | ￥703,000 (USD4,750) | ▷ お問い合わせ |
| Site Licence | ￥962,000 (USD6,500) | ▷ お問い合わせ |
| Corporate License | ￥1,295,000 (USD8,750) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| Mordor Intelligence社の本市場調査レポートでは、世界の大麻検査市場について調査・分析し、イントロダクション、調査手法、エグゼクティブサマリー、市場動向、製品・ソフトウェア/サービス別（分析機器、分光装置、消耗品、大麻検査ソフトウェア・サービス）分析、種類別（効力検査、テルペンプロファイリング、残留溶媒スクリーニング、重金属検査、マイコトキシン検査）分析、エンドユーザー別（研究所、大麻医薬品メーカー・薬局、その他）分析、地域別（北米、ヨーロッパ、アジア太平洋、中東・アフリカ、南米）分析、競争状況、市場機会・将来傾向など、以下の構成でまとめました。 ・イントロダクション ・調査手法 ・エグゼクティブサマリー ・市場動向 ・世界の大麻検査市場規模：製品・ソフトウェア/サービス別（分析機器、分光装置、消耗品、大麻検査ソフトウェア・サービス） ・世界の大麻検査市場規模：種類別（効力検査、テルペンプロファイリング、残留溶媒スクリーニング、重金属検査、マイコトキシン検査） ・世界の大麻検査市場規模：エンドユーザー別（研究所、大麻医薬品メーカー・薬局、その他） ・世界の大麻検査市場規模：地域別（北米、ヨーロッパ、アジア太平洋、中東・アフリカ、南米） ・競争状況（Agilent Technologies Inc.、Shimadzu Scientific Instruments、Merck KGaA (Sigma Aldrich)、…） ・市場機会・将来傾向 |
The cannabis testing market was valued at USD 950.9 million in 2020, and it is expected to reach USD 1,801.51 million by 2026, registering a CAGR of 11.29% during the forecast period, 2021-2026.
The impact of COVID-19 on this industry is still being studied. On one hand, due to the shutdown of non-essential labs and testing facilities across the world in response to COVID-19 induced lockdowns, sales of cannabis testing equipment and services were a bit low. However, there has been positive news too. In April 2020, two Israel-based companies, Eybna and CannaSoul, collaborated to work on a patented cannabis terpene formulation for treating COVID-19. The companies are examining the efficacy of the cannabis terpene formulation NT-VRL, which is being used to treat a diverse range of inflammatory conditions, including the cytokine storm syndrome caused by COVID-19. Collaborations and increased research in this segment are likely to create demand for cannabis testing services to isolate novel compounds.
The major factor attributing to the growth of the market is the increasing approval for the use of medical cannabis. The legal usage of cannabis for medical purposes is steadily growing but varies across countries based on the possession, distribution, cultivation, and medical indications for its consumption. In addition, there is an increasing volume of research supporting the use of marijuana for medical purposes, while some studies demonstrated it to be a potential means of fighting the opioid epidemic. Government bodies of several countries across North America, Europe, and South America have legalized the use of medicinal marijuana completely or for limited usage in certain forms on a strict basis. Globally, there are about 40 countries that allow the legal use of marijuana that is distributed through prescription or limited use in ayurvedic medicines. The use of hemp-based products has seen favorable legislation since the passage of the United States Farm Bill in 2018. The bill allowed the broad-based cultivation of hemp while restricting it to pilot programs for studying market interest in hemp-derived products. The bill explicitly allowed the transfer of hemp-derived products across state lines for commercial or other purposes. Additionally, it puts no restrictions on the sale, transport, or possession of hemp-derived products, so long as those items are produced in a manner consistent with the law. In February 2021, lawmakers in the United States stated that they were planning new legislation that would end the federal prohibition on marijuana, which has been legalized to some degree by many states. These initiatives are likely to impact the demand for cannabis testing equipment in a positive manner. As cannabis-based products find increased legislation and come under the ambit of law, the demand for testing equipment is expected to increase during the study period.
Cannabis extracts are also used to treat many neurological and mental disorders. As the incidence of these disorders increases, along with the increase in use and production of cannabis, the cannabis testing market is also expected to grow during the forecast period. According to the World Health Organization, as of 2019, approximately 450 million people suffer from such conditions, placing mental disorders among the leading causes of ill-health and disability globally. Depression is the most common mental disorder. Globally, more than 264 million people of all ages suffer from depression. More women are affected by depression than men. Furthermore, growing awareness and adoption of software services in labs testing cannabis are other factors boosting the market. However, the high cost involved in cannabis testing instruments is a major drawback of the market growth.
Key Market Trends
The Analytical Instruments Segment is Dominating the Market
The COVID-19 impact on analytical instruments has been positive. In general, due to the COVID-19 pandemic, there has been an increase in demand for analytical instruments as the production of equipment has increased significantly. Additionally, since cannabis extracts are being used for medical research, there has been sustained demand for these equipment even during the pandemic. Finally, many regions in the United States tagged cannabis dispensaries with the title of ‘essential business’. Thus, these developments are expected to positively affect the market development.
Cannabis extracts need to be tested for heavy metals, potency, pesticides, terpene profile, residual solvents, moisture, microbial and fungal growth, and mycotoxins/aflatoxin. Testing makes sure that the products are safe, while concurrently generating revenues and a return on investment. Instruments like HPLC, gas chromatography, and liquid chromatography are used extensively. A study was conducted by researchers at the Suez Canal University in Egypt between 2015 and 2018, and the results were published in January 2019. The researchers studied some of the most widely used cannabis analytical techniques. These techniques ranged from liquid chromatography (LC) to gas chromatography (GC) and others.
Chromatography techniques are used extensively for contaminant reduction. They can be cost-effective while efficiently removing contaminants like fungicides, pesticides, herbicides, synergists, and heavy metals from cannabis and hemp extracts. Chromatography can also be used for reducing THC content in cannabis extracts. They are used to separate cannabinoids like CBD, THC, CBN, CBG, etc., from cannabis extracts. Many companies like Sorbent Technologies Inc. offer exclusive chromatography-based testing and extraction products. The company manufactures dedicated chromatographic products like Adsorbents, TLC Plates, Flash Cartridges, Flash Chromatographic Systems, FPLC Columns, HPLC Columns, GC Columns, Gel Filtration, SPE Cartridges, and Syringe Filters. Many other companies like Aurum Labs, WATERS, and CannaSafe Inc., among others, offer diversified products too. The presence of major companies is expected to boost the market growth as it leads to greater product availability.
North America Dominates the Market and is Expected to do the Same in the Forecast Period
North America is expected to dominate the overall market throughout the forecast period. The market growth is due to factors such as the high prevalence of chronic diseases in the region, favorable legislation, and the presence of large companies.
According to UCB Canada Inc., a major biopharmaceutical company based in Canada, there were over 100,000 cases of Parkinson’s disease in 2018, with about 6,600 new cases of Parkinson’s diagnosed each year in Canada. The Parkinson’s Foundation of the United States estimated that around 60,000 people are diagnosed with Parkinson’s Disease each year. Cannabis-derived CBD products are used to treat some symptoms of neurological disorders like Parkinson’s. Such high incidence rates are expected to have a positive effect on the market growth. Canada was one of the first countries in the world to legalize the production and use of cannabis. In October 2019, it updated its laws to establish rules for the legal production and sale of three new classes of cannabis, which included edible cannabis, cannabis extracts, and cannabis topicals. These products need advanced purification and testing equipment for their extraction from cannabis sativa plants. Thus, regulatory changes like the one in Canada are expected to have a positive effect on the market development.
Furthermore, collaborations between major companies and an increase in the number of research efforts are some of the factors expected to drive the market growth. In this region, the United States is expected to have the maximum share due to supportive healthcare policies and the high number of patients.
Competitive Landscape
The cannabis testing market is moderately consolidated and consists of some major players. Some of the companies currently dominating the market are Agilent Technologies Inc., Shimadzu Scientific Instruments, Merck KGaA, Restek Corporation, PerkinElmer Inc., Danaher Corporation, Accelerated Technology Laboratories Inc., Steep Hill Halent Laboratories Inc., Digipath Inc., and Pharmlabs LLC.
Additional Benefits:
- The market estimate (ME) sheet in Excel format
- 3 months of analyst support
1 INTRODUCTION
1.1 Study Assumptions and Market Definition
1.2 Scope of the Study
2 RESEARCH METHODOLOGY
3 EXECUTIVE SUMMARY
4 MARKET DYNAMICS
4.1 Market Overview
4.2 Market Drivers
4.2.1 Legalization of Cannabis for Various Medical Purposes
4.2.2 Increasing Awareness regarding Cannabis for Treating Neurological Diseases
4.3 Market Restraints
4.3.1 High Cost of Analytical Instruments
4.4 Porter’s Five Forces Analysis
4.4.1 Threat of New Entrants
4.4.2 Bargaining Power of Buyers/Consumers
4.4.3 Bargaining Power of Suppliers
4.4.4 Threat of Substitute Products
4.4.5 Intensity of Competitive Rivalry
5 MARKET SEGMENTATION
5.1 By Product and Software/Service
5.1.1 Analytical Instruments
5.1.2 Spectroscopy Instruments
5.1.3 Consumables
5.1.4 Cannabis Testing Software and Services
5.2 By Type
5.2.1 Potency Testing
5.2.2 Terpene Profiling
5.2.3 Residual Solvent Screening
5.2.4 Heavy Metal Testing
5.2.5 Mycotoxin Testing
5.2.6 Other Types
5.3 By End User
5.3.1 Laboratories
5.3.2 Cannabis Drug Manufacturers and Dispensaries
5.3.3 Other End Users
5.4 Geography
5.4.1 North America
5.4.1.1 United States
5.4.1.2 Canada
5.4.1.3 Mexico
5.4.2 Europe
5.4.2.1 Germany
5.4.2.2 United Kingdom
5.4.2.3 France
5.4.2.4 Italy
5.4.2.5 Spain
5.4.2.6 Rest of Europe
5.4.3 Asia-Pacific
5.4.3.1 China
5.4.3.2 Japan
5.4.3.3 India
5.4.3.4 Australia
5.4.3.5 South Korea
5.4.3.6 Rest of Asia-Pacific
5.4.4 Middle-East and Africa
5.4.4.1 GCC
5.4.4.2 South Africa
5.4.4.3 Rest of Middle-East and Africa
5.4.5 South America
5.4.5.1 Brazil
5.4.5.2 Argentina
5.4.5.3 Rest of South America
6 COMPETITIVE LANDSCAPE
6.1 Company Profiles
6.1.1 Agilent Technologies Inc.
6.1.2 Shimadzu Scientific Instruments
6.1.3 Merck KGaA (Sigma Aldrich)
6.1.4 Restek Corporation
6.1.5 PerkinElmer Inc.
6.1.6 Danaher Corporation
6.1.7 Accelerated Technology Laboratories Inc.
6.1.8 Steep Hill Halent Laboratories Inc.
6.1.9 Digipath Inc.
6.1.10 Pharmlabs LLC
6.1.11 Sartorius AG
6.1.12 AB Sciex Pte. Ltd
6.1.13 ENCORE Labs
6.1.14 Aurum Labs
6.1.15 WATERS
7 MARKET OPPORTUNITIES AND FUTURE TRENDS